Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Aifeng Meng
Nadir CA-125 Level as Prognosis Indicator of High-Grade Serous Ovarian Cancer
Journal of Ovarian Research
Gynecology
Oncology
Obstetrics
Related publications
New in High Grade Serous Ovarian Cancer Treatment
Effective Pharmacotherapy
Targeting IDH1 as a Pro-Senescent Therapy in High-Grade Serous Ovarian Cancer
Molecular Cancer Research
Cancer Research
Oncology
Molecular Biology
VISTA Expression Is Associated With a Favorable Prognosis in Patients With High-Grade Serous Ovarian Cancer
Cancer Immunology, Immunotherapy
Cancer Research
Medicine
Oncology
Allergy
Immunology
PARP Inhibitors in Platinum-Sensitive High-Grade Serous Ovarian Cancer
Cancer Chemotherapy and Pharmacology
Cancer Research
Toxicology
Oncology
Pharmacology
CDK4/6 Inhibition as Maintenance and Combination Therapy for High Grade Serous Ovarian Cancer
Oncotarget
Oncology
PCNA-associated Factor P15PAF , Targeted by FOXM1, Predicts Poor Prognosis in High-Grade Serous Ovarian Cancer Patients
International Journal of Cancer
Cancer Research
Oncology
CBX2 Identified as Driver of Anoikis Escape and Dissemination in High Grade Serous Ovarian Cancer
Oncogenesis
Cancer Research
Molecular Biology
Low-Stage High-Grade Serous Ovarian Carcinomas
International Journal of Gynecological Pathology
Gynecology
Forensic Medicine
Pathology
Obstetrics
Proteome Profiling of Low Grade Serous Ovarian Cancer
Journal of Ovarian Research
Gynecology
Oncology
Obstetrics